Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05FGG
|
||||
Former ID |
DCL000490
|
||||
Drug Name |
Azilsartan
|
||||
Synonyms |
TAK 536; TAK-536; Azilsartan (INN/USAN)
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Takeda
|
||||
Structure |
Download2D MOL |
||||
Formula |
C25H20N4O5
|
||||
InChI |
InChI=1S/C25H20N4O5/c1-2-33-24-26-20-9-5-8-19(23(30)31)21(20)29(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-27-25(32)34-28-22/h3-13H,2,14H2,1H3,(H,30,31)(H,27,28,32)
|
||||
InChIKey |
KGSXMPPBFPAXLY-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 147403-03-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
14784428, 14833581, 24127892, 44923423, 76847538, 85210070, 96025547, 103244284, 103951947, 128380015, 128380016, 134213509, 134348772, 134358743, 135203003, 136946516, 137229628, 139483677, 140904462, 144115313, 160645922, 162009745, 162172206, 162255215, 163686146, 164045364, 164216180, 164836101, 171578929, 172918178, 175265877, 175437730, 176247781, 178103483, 185979069, 189562169, 198993038, 210280800, 211534879, 223383337, 223573547, 223573548, 223659741, 223963167, 226529482, 241036926, 241377053, 249582132, 249617126, 251916420
|
||||
Target and Pathway | |||||
Target(s) | Type-1 angiotensin II receptor | Target Info | Modulator | [531783] | |
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | Arf6 trafficking events | ||||
Arf6 signaling events | |||||
Angiopoietin receptor Tie2-mediated signaling | |||||
PathWhiz Pathway | Angiotensin Metabolism | ||||
Muscle/Heart Contraction | |||||
References | |||||
Ref 541957 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6901). | ||||
Ref 551719 | Clinical pipeline report, company report or official report of Takeda. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.